Table 6. Characteristics of patients... | American Society of Hematology

Table 6.

Characteristics of patients from 1996 to 1999 by HAART exposure before NHL diagnosis

	No prior HAART	HAART pre-NHL	χ²P value
Cases NHL	34	17
Prior AIDS	38%	29%	.57
Stage I	15%	12%	.88^6-150
Stage II	9%	12%
Stage III	6%	12%
Stage IV	70%	65%
B symptoms	91%	71%	.063
Bone marrow involvement	20%	33%	.52
ECOG > 2	53%	24%	.098
CD4 median (range) cells/mm³	107 (2-588)	214 (8-636)	.048^6-151
Mean age at NHL (y)	42.6 (SD = 9.6)	45.9 (SD = 7.6)	.22^6-152

	No prior HAART	HAART pre-NHL	χ²P value
Cases NHL	34	17
Prior AIDS	38%	29%	.57
Stage I	15%	12%	.88^6-150
Stage II	9%	12%
Stage III	6%	12%
Stage IV	70%	65%
B symptoms	91%	71%	.063
Bone marrow involvement	20%	33%	.52
ECOG > 2	53%	24%	.098
CD4 median (range) cells/mm³	107 (2-588)	214 (8-636)	.048^6-151
Mean age at NHL (y)	42.6 (SD = 9.6)	45.9 (SD = 7.6)	.22^6-152

Abbreviations explained in Table 3.

χ² for linear trend.

P-value by Mann-Whitney U test of statistics.

P-value by unpaired t test of statistics.